ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,643 | -87.1% | 50,400 | -50.0% | 0.00% | – |
| Q2 2023 | $51,408 | -19.0% | 100,800 | 0.0% | 0.00% | – |
| Q1 2023 | $63,504 | +317420.0% | 100,800 | +231.6% | 0.00% | – |
| Q4 2022 | $20 | -100.0% | 30,400 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | +2.0% | 30,400 | -26.7% | 0.00% | – |
| Q2 2022 | $51,000 | +88.9% | 41,490 | 0.0% | 0.00% | – |
| Q1 2022 | $27,000 | -40.0% | 41,490 | 0.0% | 0.00% | – |
| Q4 2021 | $45,000 | -40.0% | 41,490 | +0.5% | 0.00% | – |
| Q3 2021 | $75,000 | -30.6% | 41,290 | +1.0% | 0.00% | – |
| Q2 2021 | $108,000 | -26.5% | 40,865 | 0.0% | 0.00% | – |
| Q1 2021 | $147,000 | +38.7% | 40,865 | -2.5% | 0.00% | – |
| Q4 2020 | $106,000 | +86.0% | 41,905 | +85.0% | 0.00% | – |
| Q3 2020 | $57,000 | +1040.0% | 22,655 | +1228.7% | 0.00% | – |
| Q2 2018 | $5,000 | -93.6% | 1,705 | -91.4% | 0.00% | – |
| Q1 2018 | $78,000 | 0.0% | 19,840 | +5.3% | 0.00% | – |
| Q4 2017 | $78,000 | – | 18,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
| MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
| MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
| Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
| Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
| Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
| tru Independence LLC | 213,712 | $701,000 | 0.10% |
| Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |